Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

When Less is More: Assessing Functionality in Dermatologic Surgery

Description

Doctor Tara Jennings discusses the importance of assessing patient functionality before dermatologic surgery, especially in the geriatric population where skin cancer incidences are rising. She emphasizes that older patients, particularly those over 85, often face unique challenges in treatment decisions due to their frailty and comorbidities. Jennings highlights two essential assessment tools: the Karnofsky Performance Scale (KPS) and the Geriatric 8 (G8) scale, which help identify patients' ability to undergo surgery and predict outcomes. She emphasizes that low scores on these scales indicate higher risks for complications and mortality, suggesting a need for personalized treatment strategies. In cases where surgery is deemed inappropriate, alternatives such as active surveillance and injectable therapeutics may be more suitable, with discussions on the best management approach being critical. Examples from her practice illustrate successful applications of these palliative options, demonstrating that comprehensive assessments can lead to improved patient outcomes and quality of life.

View more

Conclusions

  • Mohs micrographic surgery (MMS) and excision are the gold standard treatments for skin cancer.
  • Functionality and frailty assessments should be used to determine the safety of surgical interventions in elderly patients.
  • Rapid assessments for functionality are important in clinical practice.
  • If surgery is not pursued, various effective palliative treatment options are available for frail patients.
  • Morbidity, treatment burden, and cost of care should be considered when choosing between treatment options.
  • Ciążyńska, M ., Kamińska-Winciorek, G ., Lange, D. et al. The incidence and clinical analysis of non-melanoma skin cancer. Sci Rep 11, 4337 (2021). https://doi.org/10.1038/s41598-021-83502-8
  • Delaney A, Shimizu I, Goldberg LH, MacFarlane DF. Life expectancy after Mohs micrographic surgery in patients aged 90 years and older. J Am Acad Dermatol. 2013 Feb;68(2):296-300. doi: 10.1016/j.jaad.2012.10.016. PMCID: PMC4251522.
  • Galles E, Parvataneni R, Stuart SE, Linos E, Grewal S, Chren MM. Patient-reported outcomes of electrodessication and curettage for treatment of nonmelanoma skin cancer. J Am Acad Dermatol. 2014 Nov;71(5):1026-8. doi: 10.1016/j.jaad.2014.06.038. PMCID: PMC4251522.
  • Eleni Linos, MD, DrPH; Rupa Parvataneni, MS; Sarah E. Stuart, BA; W. John Boscardin, PhD; C. Seth Landefeld, MD; Mary-Margaret Chren, MD. Characterized the treatment of nonmelanoma skin cancers in patients with limited life expectancy (LLE). JAMA Internal Medicine.
  • van Winden MEC, Hetterschijt CRM, Bronkhorst EM, van de Kerkhof PCM, de Jong EMGJ, Lubeek SFK. Evaluation of Watchful Waiting and Tumor Behavior in Patients With Basal Cell Carcinoma: An Observational Cohort Study of 280 Basal Cell Carcinomas in 89 Patients. JAMA Dermatol. 2021 Oct 1;157(10):1174-1181. doi: 10.1001/jamadermatol.2021.3020. PMID: 34495284; PMCID: PMC8427487.
  • Renzi M Jr, Schimmel J, Decker A, Lawrence N. Management of Skin Cancer in the Elderly. Dermatol Clin. 2019 Jul;37(3):279-286. doi: 10.1016/j.det.2019.02.003. PMID: 31084722.